Compositions and methods for treating CNS disorders
AssigneeSage Therapeutics, Inc.
InventorsGabriel Martinez Botella, Francesco G. Salituro, Albert Jean Robichaud, Boyd L. Harrison
Life of this patent
Estimating the term…
Abstract
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein , A, R1, R2, R3a, R4a, R4b, R5, R7a, and R7b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
Claims4
A compound of the formula
A pharmaceutically acceptable salt of a compound of the formula
A pharmaceutical composition comprising a compound of the formula
- and
- a pharmaceutically acceptable excipient.
A pharmaceutical composition comprising a pharmaceutically acceptable salt of a compound of the formula
- and
- a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.